Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;47(D1):D923-D929.
doi: 10.1093/nar/gky872.

Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models

Affiliations

Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models

Dieudonne van der Meer et al. Nucleic Acids Res. .

Abstract

In vitro cancer cell cultures are facile experimental models used widely for research and drug development. Many cancer cell lines are available and efforts are ongoing to derive new models representing the histopathological and molecular diversity of tumours. Cell models have been generated by multiple laboratories over decades and consequently their annotation is incomplete and inconsistent. Furthermore, the relationships between many patient-matched and derivative cell lines have been lost, and accessing information and datasets is time-consuming and difficult. Here, we describe the Cell Model Passports database; cellmodelpassports.sanger.ac.uk, which provides details of cell model relationships, patient and clinical information, as well as access to associated genetic and functional datasets. The Passports database currently contains curated details and standardized annotation for >1200 cell models, including cancer organoid cultures. The Passports will be updated with newly derived cell models and datasets as they are generated. Users can navigate the database via tissue, cancer-type, genetic feature and data availability to select a model most suitable for specific applications. A flexible REST-API provides programmatic data access and exploration. The Cell Model Passports are a valuable tool enabling access to high-dimensional genomic and phenotypic cancer cell model datasets empowering diverse research applications.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A schematic of the hierarchy used by the Cell Model Passports to capture the relationships that exist between cell models. The patient is at the pinnacle of the hierarchy (Patient 1) followed by the samples obtained (Sample 1 and 2) and models established (Model 1, 2 and 3). Establishment of further cell models from a pre-existing cell model are recorded by a parent-child link (Model 4). Image elements were obtained and adapted from Servier Medical Art under a Creative Commons Attribution 3.0 Unported License.
Figure 2.
Figure 2.
An overview of the availability of various genomic and functional datasets. Currently, mutation, copy number variation (CNV), methylation, gene expression and drug sensitivity datasets are available. To emphasize the lack of sparsity, a subset of 956 models has been highlighted for which all five datasets are available.
Figure 3.
Figure 3.
An example of a Passport Model Page. The model features and datasets are provided by the multiple information panels. Links are provided to NCI-Thesaurus definitions as well as raw and processed genomic and drug sensitivity data.

Similar articles

Cited by

References

    1. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G. et al. . Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004; 350:2129–2139. - PubMed
    1. Chapman P.B., Hauschild A., Robert C., Haanen J.B., Ascierto P., Larkin J., Dummer R., Garbe C., Testori A., Maio M. et al. . Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 2011; 364:2507–2516. - PMC - PubMed
    1. Shaw A.T., Kim D.-W., Nakagawa K., Seto T., Crinó L., Ahn M.-J., De Pas T., Besse B., Solomon B.J., Blackhall F. et al. . Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N. Engl. J. Med. 2013; 368:2385–2394. - PubMed
    1. Brown R.W., Henderson J.H.. The mass production and distribution of HeLa cells at Tuskegee Institute, 1953-55. J. Hist. Med. Allied Sci. 1983; 38:415–431. - PubMed
    1. Garnett M.J., Edelman E.J., Heidorn S.J., Greenman C.D., Dastur A., Lau K.W., Greninger P., Thompson I.R., Luo X., Soares J. et al. . Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012; 483:570–575. - PMC - PubMed

Publication types

Substances

LinkOut - more resources